Cell membrane breakage and triggering T cell infiltration are involved in human telomerase reverse transcriptase (hTERT) promoter-driven novel peptide KK-64 for liver cancer gene therapy

Liver cancer is an aggressive malignancy with exhibits both high mortality and morbidity. The current treatment options are associated with several limitations, novel specific anti-cancer drugs are urgently needed to improve liver cancer treatment. In this study, a new peptide KK-64 was designed, an...

Full description

Saved in:
Bibliographic Details
Published in:Bioengineered 2021-12, Vol.12 (2), p.12708-12721
Main Authors: Lu, Yuanhua, Ma, Jie, Lin, Jian, Tian, Yafei, Ma, Yongjun, Wang, Wei, Li, Jialin, Zhang, Hugang, Jiao, Ping
Format: Article
Language:English
Subjects:
ACP
Animals
Apoptosis
Cell Death
Cell Line, Tumor
Cell Membrane - metabolism
Cell Membrane - pathology
Cell Movement - genetics
Cell Proliferation
Genetic Therapy
Humans
KK-64
liver cancer
Liver Neoplasms - therapy
Male
Mice
Mice, Inbred BALB C
Neoplasm Invasiveness
Peptides - chemistry
Peptides - therapeutic use
Plasmids - metabolism
Promoter Regions, Genetic
Protein Structure, Secondary
Research Paper
T-Lymphocytes - immunology
Telomerase - genetics
tumor growth
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Liver cancer is an aggressive malignancy with exhibits both high mortality and morbidity. The current treatment options are associated with several limitations, novel specific anti-cancer drugs are urgently needed to improve liver cancer treatment. In this study, a new peptide KK-64 was designed, and it showed strong cytotoxicity against liver cancer cells. To obtain the tumor targeting property, a plasmid that contains KK-64 DNA fragment and driven by human telomerase reverse transcriptase (hTERT) promoter was constructed. pcTERT-kk-64 plasmid was found to specifically inhibit the viability of liver cancer cells HepG2, induce substantial apoptosis as well as damage to the cell membranes, but had minimal effects toward normal liver HL-7702 cells. Furthermore, pcTERT-kk-64 plasmids was also noted to significantly attenuate migration and invasion of HepG2 cells. The anti-tumor effect of pcTERT-kk-64 plasmid was also observed in H22 cell-bearing mice, and it appeared to cause significant tumor regression, trigger tumor cell apoptosis, and infiltrate cytotoxicity T cells to the tumor tissues after plasmids injection. Thus, pcTERT-kk-64 plasmids showed both strong cytotoxicity and tumor selectivity in vitro and in tumor-bearing mice in liver cancer models.
ISSN:2165-5979
2165-5987
DOI:10.1080/21655979.2021.2010314